Satsuma Pharmaceuticals Inc (STSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2003 | 06-2003 | 03-2003 | 12-2002 | 09-2002 | |
| Interest Income | 54,696 | 52,651 | 51,485 | 51,337 | 50,109 |
| Interest Expense | 22,368 | 22,611 | 22,914 | 23,610 | 24,245 |
| Interest Income (Net of Interest Expense) | 32,328 | 30,040 | 28,571 | 27,727 | 25,864 |
| Non-Interest Income | 8,396 | 9,689 | 7,109 | 8,439 | 8,067 |
| Sales | 40,724 | 39,729 | 35,680 | 36,166 | 33,931 |
| Credit Losses Provision | 2,850 | 2,550 | 2,250 | 4,277 | 3,277 |
| Non Interest Expenses | 24,655 | 22,604 | 21,411 | 20,405 | 21,119 |
| Pre-tax Income | 13,219 | 14,575 | 12,019 | 11,484 | 9,535 |
| Income Tax | 4,594 | 5,058 | 4,236 | 3,843 | 2,906 |
| Other Income | 35,587 | 37,186 | 34,933 | 35,094 | 33,780 |
| Net Income | $8,625 | $9,517 | $7,783 | $7,641 | $6,629 |
| EPS Basic Continuous Ops | 23.25 | 25.69 | 22.63 | 23.23 | 20.11 |
| EPS Basic Total Ops | 23.25 | 25.88 | 22.81 | 23.48 | 19.94 |
| EPS Diluted Continuous Ops | 22.65 | 25.11 | 22.11 | 22.83 | 19.67 |
| EPS Diluted Total Ops | 22.81 | 25.00 | 21.93 | 22.89 | 19.54 |
| EBITDA(a) | $N/A | $N/A | $N/A | $N/A | $N/A |